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Real-time quantification of matrix metalloproteinase and 
integrin αvβ3 expression during biomaterial-associated 
infection in a murine model 
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Abstract 
Biomaterial implants increase the risk of microbial infections due to the 
biofilm mode of growth of infecting bacteria on implant materials, in which 
bacteria are protected against antibiotic treatment and the local immune system. 
Matrix-metalloproteinases (MMPs) and cell surface integrin receptors facilitate 
transmigration of inflammatory cells toward infected or inflamed tissue. This 
study investigates the relationship between MMP- and integrin-expression and 
the clearance of infecting Staphylococcus aureus around implanted biomaterials 
in a murine model. MMP- and integrin αvβ3-expression were monitored in mice 
with and without subcutaneously implanted catheter sections in absence and 
presence of bioluminescent S. aureus Xen36. Staphylococcal persistence was 
imaged longitudinally over time using bioluminescence imaging. The activatable 
MMPSense®680 and integrin-targeted IntegriSense®750 probes were injected on 
different days after implantation and their signal intensity and localization 
monitored using fluorescence imaging. After sacrifice 7 or 16 days post-
implantation, staphylococci from catheters and surrounding tissues were cultured 
on agar-plates and presence of host inflammatory cells was histologically 
evaluated. MMP- and integrin-expression were equally enhanced in presence of 
staphylococci or biomaterials up to 7 days post-implantation, but their localization 
along the catheter sections differed. Bacterial clearance from tissue was higher in 
absence of biomaterials. Although MMP- and integrin-expression were enhanced 
in presence of both staphylococci and biomaterial, it is of clinical relevance that 
the immune system remained hampered in eradicating bacteria during the first 7 
days post-implantation in presence of biomaterials.  
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Introduction 
Biomaterials-Associated Infection (BAI) is a major complication in the use 
of biomaterial implants and devices for functional restoration (1). The on-set of 
BAI is peri- or early post-operative bacterial contamination of the implant or 
surgical site, but bacteria can reach an implant site also after implantation 
through haematogenous spreading from infection elsewhere in the body (2). Once 
adhering, the organisms adapt a so-called “biofilm mode of growth”, in which 
they embed themselves in a matrix of extracellular polymeric substances. In a 
biofilm, bacteria are protected against antibiotic treatment and the local immune 
system (3-5). Consequently, BAI often results in surgical replacement of the 
implant or device, not seldom accompanied by substantial morbidity, mortality 
and high costs to the healthcare system (2). 
Implanted biomaterials provoke an inflammatory response, known as the 
Foreign Body Reaction (FBR) (6). The onset of the FBR is accompanied by 
migration of neutrophils to the tissue adjacent to an implanted biomaterial (7). 
This acute phase resolves between a few hours to days and progresses to a type 
of inflammation characterized by chronic infiltration of mononuclear leukocytes 
particularly monocyte-derived macrophages (8,9). The inflammatory response is 
orchestrated in part by matrix metalloproteinases (MMPs) and integrins (10,11). 
MMPs are expressed by activated leukocytes and are responsible for degradation 
of extracellular matrix components (12) to facilitate migration of inflammatory 
cells and progression of inﬂammatory reactions (13). Integrins are 
transmembrane heterodimer receptors composed of α and β subunits, which 
mediate adhesion of leukocytes to the extracellular matrix (14). Integrin αvβ3 is a 
receptor for a variety of extracellular matrix proteins containing arginine-glycine-
aspartic acid (RGD) domains (15,16), also mediating adhesion of monocytes and 
macrophages to fibronectin-containing conditioning films on implanted 
biomaterial surfaces (10,17). 
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Whereas a biomaterial implant may reduce the bactericidal activity of 
phagocytes (18), the host immune response may at the same time be activated by 
bacteria adhering to a biomaterial implant or present in surrounding tissue. In 
order to separate the role of infecting bacteria and the presence of a biomaterial 
implant or device in the immune response, we here apply bio-optical imaging in a 
murine model. Bio-optical imaging is increasingly used to longitudinally monitor 
bacterial presence in live animals (19,20). Bio-optical imaging can either be 
performed in a bioluminescence or fluorescence mode (21,22). A number of 
bioluminescent bacterial strains are available for longitudinal monitoring of 
bacterial persistence, and fluorescent marker molecules have been validated for 
use in in vivo  imaging, like MMPSense®680 (23,24) and IntegriSense®750 (25-27), 
which are bio-activated by MMPs and targeted to integrin αvβ3, respectively.  
The aim of this study is to assess the relationship between MMP- and 
integrin-expression and the clearance of infecting Staphylococcus aureus, one of 
the main causative organisms of BAI, in the presence and absence of a 
biomaterial. To this end, Pebax® catheter sections (28) were subcutaneously 
implanted in mice, after which mice were injected with bioluminescent S. aureus 
Xen36. Bio-activatable and targeted fluorescent imaging probes to quantify the 
expression of MMPs and integrin αvβ3 were injected 2, 5 and 11 days after 
implantation of the catheter sections. Bio-optical imaging in the bioluminescence 
mode allows to longitudinally monitor staphylococcal clearance, while 
measurements in the fluorescence mode including molecular tomography, enable 
localization of MMPs and integrin αvβ3. Animals were sacrificed either 7 or 16 
days after implantation for ex vivo microbiological and histological evaluations. 
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Materials and methods  
Bacterial strain 
Experiments were conducted with bioluminescent S. aureus Xen36 
(PerkinElmer Inc., Waltham, MA, USA), derived from S. aureus ATCC49525, a 
clinical isolate from a patient with bacteremia (29) and used in earlier studies in 
murine models (30). Staphylococci were cultured from cryopreservative beads 
(Protect Technical Surface Consultants Ltd., UK) onto trypticase soy agar plates 
(TSA, Oxoid, Basingstoke, UK), containing 200 μg ml
-1
 kanamycin at 37°C for 24 h 
in ambient air. Prior to each experiment, one highly bioluminescent colony was 
selected using an IVIS Imaging System (IVIS® Lumina II, Imaging System, Perkin 
Elmer) to inoculate 5 mL of trypticase soy broth (TSB, Oxoid, Basingstoke, UK) at 
37°C for 24 h in ambient air. 100 μl of this culture was used to inoculate 10 ml of 
TSB and was grown for 16 h at 37°C under continuous shaking at 120 rpm. 
Bacteria were harvested by centrifugation at 5000 × g, for 5 min and washed 
twice with sterile 0.9% NaCl, after which the bacterial pellet was suspended in the 
same solution and sonicated in an ice-water bath for 3 × 10 s at 30 W (Vibra cell 
model 375, Sonics and Materials Inc., Newtown, CT, USA). Next, bacteria were 
resuspended in sterile 0.9% NaCl to a final concentration of 10
9
 bacteria per mL, 
as determined in a Bűrker–Tűrk counting chamber using phase contrast 
microscopy. 
 
Fluorescent probes  
MMPSense®680 (PerkinElmer Inc., Waltham, MA, USA) becomes 
fluorescent upon excitation around 680 nm with an emission wavelength of 
around 710 nm, after cleavage of its lysine-lysine bonds by active MMP-2, -3, -9 
and -13 (31,32). IntegriSense®750 (PerkinElmer) is a targeted ﬂuorescence 
imaging probe with an emission wavelength around 780 nm upon excitation with 
750 nm wavelength light. The probe comprises a selective non-peptide small 
molecule integrin-antagonist that binds and accumulates at integrin αvβ3 
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receptors, predominantly marking the influx of immune cells, and remains 
localized for extended periods of time (25). These fluorescent probes have 
successfully been applied to monitor MMPs or integrins in angiogenesis, tumor 
microenvironment (33-35), atherosclerosis (36) and rheumatoid arthritis (37). 
They can be used simultaneously because of their distinct and non-overlapping 
excitation and emission wavelengths. 
 
Animals and surgical procedure 
Animal experiments and experimental protocols were approved (ID-5770) 
by the Ethics Committee for Animal Experiments of the University of Groningen, 
The Netherlands. Experiments were performed in female Balb/c OlaHsd immune-
competent mice, aged 6-8 weeks with an averaged body weight of 23 ± 3.2 g 
(Harlan Netherlands BV, Horst, The Netherlands). Groups of five mice were 
housed in separate, ventilated cages with free access to water. In order to prevent 
feed-associated auto-fluorescence, the mice received an alfalfa-free diet (Diet W, 
Abdiets, Woerden, The Netherlands) ad libitum. 
Mice were randomly assigned to four groups (see Table 1). During 
surgery, mice were placed on a heating mat and anesthesia was induced with 
3.5%, and maintained at 1.5% isoflurane/O2 (Zeneca, Zoetermeer, The 
Netherlands). The ventral and dorsal side of the mice were shaved and disinfected 
with 70% ethanol. A 1 cm midline incision was made in the skin in the upper side 
of the back and a subcutaneous pocket was created by blunt dissection. In two 
groups of mice, sterile catheter sections were placed in these pockets, 1 cm in 
length and cut in half along their length, made of medical-grade polyether block 
amides (Pebax®, Raumedic® AG, Helmbrechts, Germany). The catheter sections 
were aligned with the spine and the incisions were closed using a tissue adhesive 
(Dermabond, Ethicon, Inc, Somerville, NJ). Two other groups of mice were 
subjected to surgery, but no catheter was inserted (sham-surgery). Buprenorfine 
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(0.03 mg kg
-1
) was administered subcutaneously once, as an analgesic directly 
after implantation. 
Eight mice of the sham-surgery group received an injection of 10 µl sterile 
saline, while 11 mice were injected with an inoculum of 10
7
 staphylococci in 10 µl 
saline. In the groups of mice that had received a catheter section, twenty-three 
mice were injected with 10 µl sterile saline, and 23 mice received an inoculum 
with 10
7
 bacteria in 10 µl saline alongside the catheter section. All injections were 
administered 48 h after implantation.  
For in vivo  fluorescence imaging, mice under isoflurane/O2 anesthesia 
were injected with 2 nmol of each fluorescent probe in a volume of 150 μl for 
MMPSense®680 and 100 μl for IntegriSense®750  through retro-orbital injection 
at 2, 5 and 11 days post-implantation. 
 
Table 1. Number of animals involved in the in vivo experiments for each of the four 
experimental groups. Note that only 10 out of the 15 mice sacrificed at day 16 in groups 3 
and 4 were subjected microbiological and histological analysis.  
 
Experimental groups Number of mice 
Sacrificed at 
day 7 
Sacrificed at 
day 16 
1 
 
No catheter 
section 
No bacteria 4 4 
2 
 
No catheter 
section 
Bacteria 7 4 
3 
 
Catheter section No bacteria 8 15 
4 
 
Catheter section Bacteria 8 15 
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Bio-optical imaging 
In vivo bioluminescence imaging of bacterial presence 
Bacterial clearance was evaluated using an In Vivo Imaging System (IVIS® 
Spectrum Perkin Elmer) on selected days over a period of 7 or 16 days. For 
imaging, mice were placed in the IVIS under 1.5% isoflurane/O2 anaesthesia, with 
their back exposed to the camera. After acquiring a grey-scale photograph, a 
bioluminescence image was obtained (exposure time 5 min) using a 21x21 cm 
field of view, binning of 4, 1/f aperture and open filters. Images were 
automatically corrected for background noise. Regions of Interest (ROIs) of 5 cm
2 
were manually created for each mouse and imaging session. Total photon counts 
over the ROIs were converted to photon fluxes (p s
-1
) due to bioluminescence 
using Living Image software (Perkin Elmer). 
 
In vivo fluorescence imaging of MMP- and integrin-expression 
The fluorescence fluxes generated from the MMPs and integrin αvβ3 
probes were quantified in the IVIS® system 24 h after their administration at 3, 6 
and 12 days post-implantation, and in addition to the time points when 
bioluminescence was measured. Images were acquired using epi-illumination, 
with excitation/emission at 675/710 nm for MMPSense®680, and 720/820 nm for 
IntegriSense®750. These filter combinations were chosen to avoid leakage of 
excitation light through the emission filter and optimize the ratio between 
fluorescence from the probe and auto-fluorescence from murine tissue. Manually 
created ROIs were of equal size (7 cm
2
) for each mouse and imaging session 
Four randomly selected mice in each group of infected and non-infected 
mice with an implanted catheter section were imaged using a fluorescence 
molecular tomography system (FMT 2500™, PerkinElmer) when under anesthesia 
for the IVIS analysis (25). Three-dimensional distributions of the probes around 
the implant site were obtained using dedicated FMT software with a resolution of 
1 mm (i.e. voxel size is 1 mm
3
) and calibrated against the fluorescence flux of a 0.4 
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μM solution of each of the probes in 100 μl demineralized water, according to the 
manufacturer’s instructions. The 3D-images were acquired using trans-
illumination with an excitation laser beam with a wavelength of 670 nm for 
MMPSense®680, and 745 nm for integriSense®750. Emission wavelengths were 
690 and 780 nm respectively, as pre-configured by the manufacturer. 
In order to determine to what extent MMP- and integrin-expression are 
co-localized and result from the presence of catheter sections, probe distributions 
around the catheter sections were analyzed using autocorrelation functions. 
These autocorrelations were calculated for each mouse in a 2D-slice of the 3D-
image, aligned along the coronal plane of the mouse at the position of the 
implant. Autocorrelations were calculated in the x-direction parallel to the length 
of the catheter section and in the y-direction perpendicular to the catheter length 
over an angular width of ±10 degrees. In the x-direction, the autocorrelation was 
calculated using MATLAB routines (The MathWorksinc, Natick, MA, USA) 
according to  
                                                                                                                  
(1) 
                 
 
in which F(xi) is the fluorescence concentration at pixel location xi and n(h) is the 
number of pixels at a distance h. Autocorrelations in the y-direction were 
calculated by changing x into y. Autocorrelations presented were normalized with 
respect to the autocorrelation at a distance of 1 mm from the catheter section. 
 
Microbiological and histological ex vivo evaluations 
After sacrifice at day 7 or 16 (see Table 1), an incision was made in the 
dorsal skin, the subcutaneous layer with adjacent skin was prepared free to make 
the catheter section visible and a disk-shaped standardized biopsy of 12 mm in 
diameter, comprising the catheter section with surrounding tissue, was taken. 
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Biopsies were cut in halves, for quantitative microbiological culture and 
histological analysis, respectively. Five randomly chosen biopsies from each of the 
groups with implanted catheter sections taken 16 days after sacrifice were only 
visually inspected for the signs of infection and not further processed.  
For microbiological culturing, a catheter section was carefully separated 
from the surrounding tissue and both were separately placed in 1 ml of 0.9% NaCl. 
Next, the catheter section and tissues were sonicated for 5 s in 0.9% NaCl (500 µl), 
after which the samples were 10-fold serially diluted and plated on blood agar 
plates. Agar plates were incubated for 24 h at 37°C after which the numbers of 
colony forming units (CFUs) were counted.     
For histological analysis, biopsy specimens were fixed in 10% phosphate-
buffered formaldehyde, embedded in plastic 
(methylmethacrylate/butylmethacrylate; Merck Schuchart, Hohenbrunn, 
Germany), and 3 μm sections were cut, deplastified, stained with hematoxilin-
eosin and examined by light microscopy, or immuno-stained for MMP-2 and 
MMP-9 with anti- MMP2/MMP-9 antibodies (Millipore, Amsterdam, The 
Netherlands), and visualized with Vector Red and Vector Blue, respectively. 
Images of the immuno-stained sections were recorded with a Nuance 
multispectral imaging camera (Perkin Elmer), allowing display of the antigens in 
pseudocolours (38). 
 
Statistical analysis 
Data were analyzed using SPSS 16 (SPSS Inc., Chicago, IL, USA). 
Bioluminescence and fluorescence fluxes are represented as medians with 
interquartile ranges for each group of mice. In vivo bio-optical imaging and ex vivo 
culturing data were analyzed using a Mann-Whitney test to assess significant 
differences between groups of mice. p-Values of <0.05 were considered to 
indicate a statistically significant difference. 
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Results 
In vivo bioluminescence imaging  
Bioluminescence fluxes from mice without and with implanted catheter 
sections are shown in Fig. 1. Initially, in the presence of staphylococci, the 
bioluminescence fluxes were equally high in groups of mice without (Fig. 1A) and 
with (Fig. 1B) catheter sections. Whereas the bioluminescence in the group of 
mice without a catheter section steadily and consistently decreased over time in 
all mice, in the presence of a catheter section strongly elevated levels of 
staphylococcal bioluminescence were observed in two mice, especially at days 7-9 
post-implantation.  
 
In vivo fluorescence imaging of MMPs and integrin αvβ3  
Fig. 2. summarizes the fluorescence fluxes in the different groups of mice 
at different time points post-implantation. Three days post-implantation in 
absence of staphylococci, fluorescence was significantly higher in mice with an 
implanted catheter section than in mice without an implanted catheter section, 
and this difference continued to exist up to day 12. At day 6, staphylococcal 
presence increased the fluorescence fluxes from both probes significantly, both in 
the groups without and with implant. Twelve days post-implantation however, no 
significant differences related to the presence of bacteria were recorded, but the 
signal of the probes in the mice carrying an implant was still significantly (p <0.05) 
higher than in mice without implant. 
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Figure 1. Bioluminescence fluxes in mice without (A) and with (B) an implanted catheter 
section arising from the presence of bioluminescent S. aureus Xen36 as a function of time 
post-implantation. Data are presented as medians with interquartile ranges. 
Note that up to day 7 data are from 23 mice, while after day 7 data represent values of 
the remaining 15 mice, since 8 mice of the groups were sacrificed at day 7 (Table 1). 
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Figure 2. Fluorescence fluxes generated by MMP activated (left) and integrin αvβ3 
targeted (right) probes  as a function of time post-implantation in the four different 
groups of mice (see Table 1). Probes were injected at 2, 5, and 11 days after implantation 
of the catheter sections and mice were imaged  24 h after injection. Data are presented as 
medians with interquartile ranges. Note that the different groups include different 
numbers of mice (for details see Table 1). 
* indicate significant differences as compared with the group of mice without a catheter 
section at the same day post-implantation.
 
FMT images revealed that both probes distributed predominantly around 
the catheter sections (Fig. 3A). The concentrations of fluorophores showed high 
correlations over only 5 mm in the direction perpendicular to the catheter section 
for both MMP- and integrin probes, whereas correlations parallel to it were high 
over 10 to 12 mm (Fig. 3B). Interestingly, the signals of the integrin probe showed 
higher correlations parallel to the catheter section than of MMP probes in all 
groups of mice, indicating that these probes did not fully co-localize, although co-
localization was stronger in the presence of staphylococci. 
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Figure 3. Distribution of MMP activatable and integrin αvβ3 targeted probes in mice with 
an implanted and catheter section challenged with S. aureus, as obtained from 3D-
fluorescence tomography (A). Autocorrelations of fluorescence distributions in mice that 
carry an implanted catheter section in absence (left panel) or presence (right panel) of S. 
aureus Xen36 in the direction parallel and perpendicular to the catheter section at three 
time points after implantation. Error bars represent standard deviations of four mice in 
each group (B). 
 
Ex vivo evaluation of catheter sections and surrounding tissues 
Microbiological culturing  
Seven days post-implantation, no significant differences in numbers of 
CFU could be observed in tissue and catheter section samples in both groups of 
bacterially challenged mice (Fig. 4). At 16 days post-implantation however, the 
number of CFUs were significantly lower in the mice without a catheter section, 
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whereas the number of CFUs in the mice with a catheter section, both in the 
tissue and on the catheter section, were not significantly lower.  
 
Histological evaluation  
Regardless of the presence of catheter sections, tissues of mice which had 
been inoculated with staphylococci and sacrificed at day 7 demonstrated strong 
inflammation with a dense infiltrate of phagocytic cells, predominantly 
neutrophils and macrophages (Fig. 5). The inflammatory reaction was milder at 
day 16 post-implantation than at day 7, with strongest inflammation in the mice 
with a catheter section and bacteria. At 16 days, strong influx of cells expressing 
predominantly MMP-9, was observed adjacent to the catheter sections both in 
absence and presence of staphylococci (Fig. 6). In absence of implants the 
response was far less intense.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Log CFUs of S. aureus Xen36 retrieved from tissues and catheter sections from 
mice without or with implanted catheter section after sacrifice at day 7 and day 16. Note 
that all mice were challenged with staphylococci 48 hours after surgery. Since no bacteria 
were injected in the control group, all cultures of this group were negative. The asterisk 
(*) indicates a significant decrease in number of CFUs as compared to the number of CFUs 
counted at day 7 in the same group of mice without a catheter section.  
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Figure 5. Hematoxylin–eosin stained sections of biopsies retrieved from mice subjected to 
sham surgery or implanted with catheter sections, injected with saline or with S. aureus 
Xen36,  48 h after surgery, after 7 (left panel) and 16 (right panel) days post-surgery. 
Seven days post-surgery, a high density of purple-stained neutrophils and macrophages 
can be seen in all groups, except in the group with no implanted catheter section and in 
absence of staphylococci. In comparison, 16 days after sacrifice, biopsies in all groups 
showed a less intense inflammatory response. Bars indicate 50 µm, arrows indicate the 
location of the interface with the catheter section. 
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Figure 6. MMP-2 and MMP-9 expression in tissue of mice in absence and presence of S. 
aureus for the sham-surgery group (without a catheter section), and the group of mice 
with implanted catheter sections after sacrifice at day 16. Sections were stained for MMP-
2 (red) and MMP-9 (blue). The left panels are light microscopic images and the right 
panels are pseudocolour images of corresponding sections.  MMP-2 expression was seen 
in muscle fibers (e.g. in sham-surgery group with bacteria). Bars represent 20 µm. 
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Discussion 
We evaluated the simultaneous expression of MMPs and integrin αvβ3 
around an implanted biomaterial in absence and presence of S. aureus using bio-
optical imaging in a murine model. Through the combined use of in vivo 
bioluminescence and fluorescence imaging techniques, it was established that 
bacterial clearance was faster in absence than in presence of an implanted 
biomaterial (Fig. 4), despite enhanced expression of MMPs and integrin αvβ3 in 
the latter case (Fig. 2). Apparently, expression rate of MMPs and integrin αvβ3 
does not correlate with the efficacy of the immune clearance of S. aureus in 
experimental murine biomaterial-associated infection.  
MMPs are involved in multiple physiological and pathological processes 
such as infections, both in humans and in mice (39,40). Expression of MMPs by 
neutrophils and monocytes can be induced by infecting bacteria (41-43). 
Staphylococci also produce MMP-like proteases (44,45) themselves that activate 
the MMPSense®680 probe (Fig. 7). However, we assume that the fluorescence 
flux from staphylococcal MMP-like proteases can be neglected relative to the 
fluorescence flux due to MMPs of neutrophils and monocytes, since after 
staphylococcal inoculation, we observed a similar staphylococcal presence in mice 
with and without a catheter section (Figs. 1 and 4), but with a clearly enhanced 
fluorescence flux from MMPSense®680 only in the presence of an implanted 
catheter section. Moreover, integrin expression paralleled MMP expression.  
Integrins have been studied both in humans and in animal models of 
inflammation (46,47) but there is no in vivo information regarding the activation 
of integrins during BAI.  In vitro, integrins serve as adhesion molecules to mediate 
cell adhesion to protein-coated biomaterials and to stimulate bacterial uptake 
into phagocytic cells. It has been suggested that integrin signaling at the 
transcriptional level regulates MMP expression (48,49). It may be hypothesized 
therefore, that MMPs and integrin activation are co-localized. The autocorrelation 
analysis (Fig. 3) demonstrates that the distribution of both biomarkers resembles 
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the dimensions of the implanted catheter sections. However, the integrin signals 
aligned more strongly and over longer distances parallel to the catheter sections 
than those of the MMPs. Integrins and MMPs thus were not fully co-localized, 
implying induction of expression of MMPs is not solely due to integrin signaling. 
The lack of co-localization seems to disappear as soon as staphylococci are 
present. This may be due to the fact that staphylococci, when evenly distributed 
over the surface of the catheter section, give rise to MMP activation in immune 
cells (41-43), in addition to the activation caused by the biomaterial itself. 
As a major advantage of bio-optical imaging, bacterial persistence around 
an implanted biomaterial and the associating FBR can be monitored in a 
quantitative way in one and the same animal, strongly reducing the numbers of 
animals needed. At 16 days, the bioluminescence of the mice correlated with 
results from microbiological culturing and the decrease in fluorescence fluxes due 
to activation both MMP and integrin probes correlated with the decrease in the 
density of inflammatory cells from day 7 to day 16 in histologically examined 
specimens.  
In conclusion, through the combined use of bioluminescent and 
fluorescent in vivo imaging techniques, it has been demonstrated for the first time 
that MMP and integrin expression are simultaneously enhanced in presence of 
staphylococci or biomaterials for up to 7 days post-implantation in mice. 
Activation was strongest in presence of staphylococci together with an implanted 
biomaterial. In accordance with the notion that biomaterials increase 
susceptibility to infection, bacterial clearance was higher in absence than in 
presence of implanted biomaterials, indicating that expression of MMPs and 
integrin was not correlated with an effective immune response and bacterial 
clearance in BAI. As a protracted and high level pro-inflammatory response may 
be associated with increased susceptibility of infection (50), the up-regulated 
expression of MMPs and integrin may in fact be indicators of an exaggerated 
inflammatory response, which may be the cause of increased susceptibility to 
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infection in patients carrying a biomaterial implant, rather than a sign of an 
effective immune response.   
 
 
 
Figure. 7. Fluorescence (FLI) and bioluminescence images (BLI) of bioluminescent S. aureus 
Xen36 colonies grown on TSA with or without 2 nmol MMPSense®680 added per plate, 
taken in order to evaluate whether bacterial proteases are able to activate the 
MMPSense®680probe. From a comparison of the bioluminescence and fluorescence 
images, it can be concluded that S. aureus Xen36 is able to activate MMPsense®680. 
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